SÃO PAULO – Ambev S.A. (NYSE: ABEV; BVMF: ABEV3) closed the trading week on a down note, with its U.S.-listed shares settling at $3.00 on Friday, August 7. That represented a 3.5% decline from the July 31 close, despite a marked improvement in the company's cash conversion during the second quarter. Markets in New York and São Paulo were closed on Saturday.
The divergence between cash generation and share price performance highlights the central challenge facing the beverage giant: while operational cash flow has strengthened significantly, underlying demand remains uneven across its business units. In the second quarter, operating cash flow reached 135% of normalized profit, up from 108% in the same period last year. However, only two of the company's five reporting segments posted volume growth, underscoring the persistent weakness in certain markets.
Analysts remain cautious on the stock. Among a panel of three analysts tracked, none currently hold a buy rating. The consensus price target stands at $3.20, implying a modest upside of just 6.7% from Friday's close. This tepid outlook reflects concerns that robust cash flow alone may not be enough to drive a re-rating if volume growth fails to broaden.
Quarterly Performance: Cash Flow vs. Volume
Ambev's second-quarter results, released earlier in the week, showed operating cash flow of R$4.711 billion, a 54.5% increase year-over-year. Normalized profit rose 23.3% to R$3.493 billion. The cash flow-to-profit conversion ratio expanded by 27.2 percentage points to 134.9%, driven by improved working capital management. Normalized EBITDA margin also improved, rising 100 basis points to 31.6% on a reported basis, or 80 basis points organically.
Chief Executive Carlos Lisboa touted "another quarter of beer volume growth" and strong top- and bottom-line performance. Normalized EBITDA grew 8.9% year-over-year. However, revenue came in below expectations at R$20.15 billion, missing the consensus estimate of R$20.83 billion by 3.3%. This revenue shortfall may explain why the market has not rewarded the company for its cash generation.
Segment Breakdown
Across the five business units, organic volume trends were mixed. The Central America and Caribbean segment led with 5.4% volume growth and 7.1% revenue growth. Brazil beer volumes rose 5.0%, with revenue up 8.9%. Canada saw volumes decline 1.8% but revenue grow 2.1%. Latin America South volumes fell 2.9%, though revenue advanced 4.4%. Brazil non-alcoholic beverages volumes dropped 4.4%, with revenue up 1.4%.
Pricing and product mix were the primary drivers of revenue growth, as consolidated net revenue per hectoliter increased 4.6% organically. This helped offset lower physical sales in most divisions. Brazil beer remained the standout performer, with normalized EBITDA up 12.8% on the back of market share gains, a recovering sector, and additional demand from the World Cup. Premium beer volumes grew in the high teens, while no-alcohol beer advanced in the low twenties. Michelob Ultra volumes in Brazil and Argentina more than tripled during the quarter.
In contrast, Brazil's non-alcoholic beverage segment saw volumes decline 4.4%, although EBITDA rose 13.8% and margin expanded by 320 basis points, thanks to revenue gains and cost control.
Capital Returns and Market Reaction
Ambev has been active in returning capital to shareholders. By July 30, the company had distributed nearly R$5.9 billion to shareholders this year, completing about 95% of its buyback program. It also authorized a fresh R$1.1 billion distribution via interest-on-capital.
Despite these measures, the stock underperformed the Ibovespa index last week by approximately 0.5 percentage point. Trading volume on Friday was elevated, with 37.8 million shares changing hands, about 33% above the 65-day average.
Analyst Sentiment and Outlook
Recommendation samples show a predominantly neutral stance. In a three-month sample, zero analysts were bullish, two were neutral, and one was bearish, with an average target of $3.20. A wider sample of 19 analysts showed four bullish, ten neutral, and five bearish, with an average target of $3.23, implying 7.7% upside. Neutral ratings dominate, and price targets suggest limited valuation upside.
Investors will be watching upcoming economic data, including Brazil's July inflation figures due Tuesday, June services data on Wednesday, and June retail sales on Thursday. These releases come after the central bank cut the Selic rate to 14.00% on August 5. Ambev's next quarterly results are scheduled for October 29.
Risks and Considerations
Key risks include a potential taper in World Cup-related demand, continued softness in Brazil's non-alcoholic beverage sales, and elevated interest rates that may constrain consumer spending. Ambev maintains its guidance for Brazil beer cash costs per hectoliter to rise between 4.5% and 7.5% this year.
For investors, the key metric to watch is breadth of volume recovery rather than cash generation alone. A more widespread improvement in volumes would validate the improved cash conversion and support a potential re-rating. Until then, the prevailing analyst view remains Hold.